APO Research
Talk to an analyst

APO RESEARCH · REPORT

Josamycin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Josamycin Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchJosamycin Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Josamycin Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Josamycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Josamycin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Josamycin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Josamycin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Josamycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Josamycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Josamycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Josamycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Josamycin include Tosun Pharm, CSPC, SINE, Minsheng Pharma, BioChemPartner, Guilin Pharma, Bayer, Guanghua Pharma and SAJA Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Josamycin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Josamycin, also provides the sales of main regions and countries. Of the upcoming market potential for Josamycin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Josamycin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Josamycin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Josamycin sales, projected growth trends, production technology, application and end-user industry.

Josamycin Segment by Company

Tosun Pharm

CSPC

SINE

Minsheng Pharma

BioChemPartner

Guilin Pharma

Bayer

Guanghua Pharma

SAJA Pharma

Ferrer International

Dragon Pharm

Astellas

Josamycin Segment by Type

99% Purity Type

98% Purity Type

95% Purity Type

Others

Josamycin Segment by Application

Josamycin Tablets

Propidinium Propionate Granule

Others

Josamycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Josamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Josamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Josamycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Josamycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Josamycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Josamycin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Josamycin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 99% Purity Type Major Manufacturers Table 3. 98% Purity Type Major Manufacturers Table 4. 95% Purity Type Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Josamycin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Josamycin Tablets Major Manufacturers Table 8. Propidinium Propionate Granule Major Manufacturers Table 9. Others Major Manufacturers Table 10. Josamycin Industry Trends Table 11. Josamycin Industry Drivers Table 12. Josamycin Industry Opportunities and Challenges Table 13. Josamycin Industry Restraints Table 14. Global Josamycin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Josamycin Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Josamycin Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Josamycin Revenue Market Share by Region (2021-2026) Table 18. Global Josamycin Revenue Market Share by Region (2027-2032) Table 19. Global Josamycin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 20. Global Josamycin Sales by Region (2021-2026) & (tons) Table 21. Global Josamycin Sales by Region (2027-2032) & (tons) Table 22. Global Josamycin Sales Market Share by Region (2021-2026) Table 23. Global Josamycin Sales Market Share by Region (2027-2032) Table 24. Global Josamycin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Josamycin Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Josamycin Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Josamycin Sales Market Share by Manufacturers (2021-2026) Table 28. Global Josamycin Sales Price (US$/ton) of Manufacturers (2021-2026) Table 29. Global Josamycin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Josamycin Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Josamycin Manufacturers, Product Type & Application Table 32. Global Josamycin Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Josamycin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Josamycin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Josamycin Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Josamycin Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Josamycin Revenue Market Share by Type (2021-2026) Table 39. Global Josamycin Revenue Market Share by Type (2027-2032) Table 40. Global Josamycin Sales by Type 2021 VS 2025 VS 2032 (tons) Table 41. Global Josamycin Sales by Type (2021-2026) & (tons) Table 42. Global Josamycin Sales by Type (2027-2032) & (tons) Table 43. Global Josamycin Sales Market Share by Type (2021-2026) Table 44. Global Josamycin Sales Market Share by Type (2027-2032) Table 45. Global Josamycin Price by Type (2021-2026) & (US$/ton) Table 46. Global Josamycin Price by Type (2027-2032) & (US$/ton) Table 47. Global Josamycin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Josamycin Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Josamycin Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Josamycin Revenue Market Share by Application (2021-2026) Table 51. Global Josamycin Revenue Market Share by Application (2027-2032) Table 52. Global Josamycin Sales by Application 2021 VS 2025 VS 2032 (tons) Table 53. Global Josamycin Sales by Application (2021-2026) & (tons) Table 54. Global Josamycin Sales by Application (2027-2032) & (tons) Table 55. Global Josamycin Sales Market Share by Application (2021-2026) Table 56. Global Josamycin Sales Market Share by Application (2027-2032) Table 57. Global Josamycin Price by Application (2021-2026) & (US$/ton) Table 58. Global Josamycin Price by Application (2027-2032) & (US$/ton) Table 59. Tosun Pharm Company Information Table 60. Tosun Pharm Business Overview Table 61. Tosun Pharm Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 62. Tosun Pharm Josamycin Product Portfolio Table 63. Tosun Pharm Recent Development Table 64. CSPC Company Information Table 65. CSPC Business Overview Table 66. CSPC Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 67. CSPC Josamycin Product Portfolio Table 68. CSPC Recent Development Table 69. SINE Company Information Table 70. SINE Business Overview Table 71. SINE Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 72. SINE Josamycin Product Portfolio Table 73. SINE Recent Development Table 74. Minsheng Pharma Company Information Table 75. Minsheng Pharma Business Overview Table 76. Minsheng Pharma Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 77. Minsheng Pharma Josamycin Product Portfolio Table 78. Minsheng Pharma Recent Development Table 79. BioChemPartner Company Information Table 80. BioChemPartner Business Overview Table 81. BioChemPartner Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 82. BioChemPartner Josamycin Product Portfolio Table 83. BioChemPartner Recent Development Table 84. Guilin Pharma Company Information Table 85. Guilin Pharma Business Overview Table 86. Guilin Pharma Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 87. Guilin Pharma Josamycin Product Portfolio Table 88. Guilin Pharma Recent Development Table 89. Bayer Company Information Table 90. Bayer Business Overview Table 91. Bayer Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 92. Bayer Josamycin Product Portfolio Table 93. Bayer Recent Development Table 94. Guanghua Pharma Company Information Table 95. Guanghua Pharma Business Overview Table 96. Guanghua Pharma Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 97. Guanghua Pharma Josamycin Product Portfolio Table 98. Guanghua Pharma Recent Development Table 99. SAJA Pharma Company Information Table 100. SAJA Pharma Business Overview Table 101. SAJA Pharma Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 102. SAJA Pharma Josamycin Product Portfolio Table 103. SAJA Pharma Recent Development Table 104. Ferrer International Company Information Table 105. Ferrer International Business Overview Table 106. Ferrer International Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 107. Ferrer International Josamycin Product Portfolio Table 108. Ferrer International Recent Development Table 109. Dragon Pharm Company Information Table 110. Dragon Pharm Business Overview Table 111. Dragon Pharm Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 112. Dragon Pharm Josamycin Product Portfolio Table 113. Dragon Pharm Recent Development Table 114. Astellas Company Information Table 115. Astellas Business Overview Table 116. Astellas Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 117. Astellas Josamycin Product Portfolio Table 118. Astellas Recent Development Table 119. North America Josamycin Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Josamycin Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Josamycin Sales by Type (2021-2026) & (tons) Table 122. North America Josamycin Sales by Type (2027-2032) & (tons) Table 123. North America Josamycin Sales Price by Type (2021-2026) & (US$/ton) Table 124. North America Josamycin Sales Price by Type (2027-2032) & (US$/ton) Table 125. North America Josamycin Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Josamycin Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Josamycin Sales by Application (2021-2026) & (tons) Table 128. North America Josamycin Sales by Application (2027-2032) & (tons) Table 129. North America Josamycin Sales Price by Application (2021-2026) & (US$/ton) Table 130. North America Josamycin Sales Price by Application (2027-2032) & (US$/ton) Table 131. North America Josamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Josamycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. North America Josamycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. North America Josamycin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 135. North America Josamycin Sales by Country (2021-2026) & (tons) Table 136. North America Josamycin Sales by Country (2027-2032) & (tons) Table 137. North America Josamycin Sales Price by Country (2021-2026) & (US$/ton) Table 138. North America Josamycin Sales Price by Country (2027-2032) & (US$/ton) Table 139. United States Josamycin Revenue (2021-2032) & (US$ Million) Table 140. Canada Josamycin Revenue (2021-2032) & (US$ Million) Table 141. Mexico Josamycin Revenue (2021-2032) & (US$ Million) Table 142. Europe Josamycin Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe Josamycin Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe Josamycin Sales by Type (2021-2026) & (tons) Table 145. Europe Josamycin Sales by Type (2027-2032) & (tons) Table 146. Europe Josamycin Sales Price by Type (2021-2026) & (US$/ton) Table 147. Europe Josamycin Sales Price by Type (2027-2032) & (US$/ton) Table 148. Europe Josamycin Revenue by Application (2021-2026) & (US$ Million) Table 149. Europe Josamycin Revenue by Application (2027-2032) & (US$ Million) Table 150. Europe Josamycin Sales by Application (2021-2026) & (tons) Table 151. Europe Josamycin Sales by Application (2027-2032) & (tons) Table 152. Europe Josamycin Sales Price by Application (2021-2026) & (US$/ton) Table 153. Europe Josamycin Sales Price by Application (2027-2032) & (US$/ton) Table 154. Europe Josamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Europe Josamycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Europe Josamycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Europe Josamycin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 158. Europe Josamycin Sales by Country (2021-2026) & (tons) Table 159. Europe Josamycin Sales by Country (2027-2032) & (tons) Table 160. Europe Josamycin Sales Price by Country (2021-2026) & (US$/ton) Table 161. Europe Josamycin Sales Price by Country (2027-2032) & (US$/ton) Table 162. Germany Josamycin Revenue (2021-2032) & (US$ Million) Table 163. France Josamycin Revenue (2021-2032) & (US$ Million) Table 164. U.K. Josamycin Revenue (2021-2032) & (US$ Million) Table 165. Italy Josamycin Revenue (2021-2032) & (US$ Million) Table 166. Russia Josamycin Revenue (2021-2032) & (US$ Million) Table 167. Spain Josamycin Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Josamycin Revenue (2021-2032) & (US$ Million) Table 169. Switzerland Josamycin Revenue (2021-2032) & (US$ Million) Table 170. Sweden Josamycin Revenue (2021-2032) & (US$ Million) Table 171. Poland Josamycin Revenue (2021-2032) & (US$ Million) Table 172. China Josamycin Revenue by Type (2021-2026) & (US$ Million) Table 173. China Josamycin Revenue by Type (2027-2032) & (US$ Million) Table 174. China Josamycin Sales by Type (2021-2026) & (tons) Table 175. China Josamycin Sales by Type (2027-2032) & (tons) Table 176. China Josamycin Sales Price by Type (2021-2026) & (US$/ton) Table 177. China Josamycin Sales Price by Type (2027-2032) & (US$/ton) Table 178. China Josamycin Revenue by Application (2021-2026) & (US$ Million) Table 179. China Josamycin Revenue by Application (2027-2032) & (US$ Million) Table 180. China Josamycin Sales by Application (2021-2026) & (tons) Table 181. China Josamycin Sales by Application (2027-2032) & (tons) Table 182. China Josamycin Sales Price by Application (2021-2026) & (US$/ton) Table 183. China Josamycin Sales Price by Application (2027-2032) & (US$/ton) Table 184. Asia Josamycin Revenue by Type (2021-2026) & (US$ Million) Table 185. Asia Josamycin Revenue by Type (2027-2032) & (US$ Million) Table 186. Asia Josamycin Sales by Type (2021-2026) & (tons) Table 187. Asia Josamycin Sales by Type (2027-2032) & (tons) Table 188. Asia Josamycin Sales Price by Type (2021-2026) & (US$/ton) Table 189. Asia Josamycin Sales Price by Type (2027-2032) & (US$/ton) Table 190. Asia Josamycin Revenue by Application (2021-2026) & (US$ Million) Table 191. Asia Josamycin Revenue by Application (2027-2032) & (US$ Million) Table 192. Asia Josamycin Sales by Application (2021-2026) & (tons) Table 193. Asia Josamycin Sales by Application (2027-2032) & (tons) Table 194. Asia Josamycin Sales Price by Application (2021-2026) & (US$/ton) Table 195. Asia Josamycin Sales Price by Application (2027-2032) & (US$/ton) Table 196. Asia Josamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Asia Josamycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. Asia Josamycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. Asia Josamycin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 200. Asia Josamycin Sales by Country (2021-2026) & (tons) Table 201. Asia Josamycin Sales by Country (2027-2032) & (tons) Table 202. Asia Josamycin Sales Price by Country (2021-2026) & (US$/ton) Table 203. Asia Josamycin Sales Price by Country (2027-2032) & (US$/ton) Table 204. Japan Josamycin Revenue (2021-2032) & (US$ Million) Table 205. South Korea Josamycin Revenue (2021-2032) & (US$ Million) Table 206. India Josamycin Revenue (2021-2032) & (US$ Million) Table 207. Australia Josamycin Revenue (2021-2032) & (US$ Million) Table 208. Taiwan Josamycin Revenue (2021-2032) & (US$ Million) Table 209. Southeast Asia Josamycin Revenue (2021-2032) & (US$ Million) Table 210. SAMEA Josamycin Revenue by Type (2021-2026) & (US$ Million) Table 211. SAMEA Josamycin Revenue by Type (2027-2032) & (US$ Million) Table 212. SAMEA Josamycin Sales by Type (2021-2026) & (tons) Table 213. SAMEA Josamycin Sales by Type (2027-2032) & (tons) Table 214. SAMEA Josamycin Sales Price by Type (2021-2026) & (US$/ton) Table 215. SAMEA Josamycin Sales Price by Type (2027-2032) & (US$/ton) Table 216. SAMEA Josamycin Revenue by Application (2021-2026) & (US$ Million) Table 217. SAMEA Josamycin Revenue by Application (2027-2032) & (US$ Million) Table 218. SAMEA Josamycin Sales by Application (2021-2026) & (tons) Table 219. SAMEA Josamycin Sales by Application (2027-2032) & (tons) Table 220. SAMEA Josamycin Sales Price by Application (2021-2026) & (US$/ton) Table 221. SAMEA Josamycin Sales Price by Application (2027-2032) & (US$/ton) Table 222. SAMEA Josamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 223. SAMEA Josamycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 224. SAMEA Josamycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 225. SAMEA Josamycin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 226. SAMEA Josamycin Sales by Country (2021-2026) & (tons) Table 227. SAMEA Josamycin Sales by Country (2027-2032) & (tons) Table 228. SAMEA Josamycin Sales Price by Country (2021-2026) & (US$/ton) Table 229. SAMEA Josamycin Sales Price by Country (2027-2032) & (US$/ton) Table 230. Brazil Josamycin Revenue (2021-2032) & (US$ Million) Table 231. Argentina Josamycin Revenue (2021-2032) & (US$ Million) Table 232. Chile Josamycin Revenue (2021-2032) & (US$ Million) Table 233. Colombia Josamycin Revenue (2021-2032) & (US$ Million) Table 234. Peru Josamycin Revenue (2021-2032) & (US$ Million) Table 235. Saudi Arabia Josamycin Revenue (2021-2032) & (US$ Million) Table 236. Israel Josamycin Revenue (2021-2032) & (US$ Million) Table 237. UAE Josamycin Revenue (2021-2032) & (US$ Million) Table 238. Turkey Josamycin Revenue (2021-2032) & (US$ Million) Table 239. Iran Josamycin Revenue (2021-2032) & (US$ Million) Table 240. Egypt Josamycin Revenue (2021-2032) & (US$ Million) Table 241. Key Raw Materials Table 242. Raw Materials Key Suppliers Table 243. Josamycin Distributors List Table 244. Josamycin Customers List Table 245. Research Programs/Design for This Report Table 246. Authors List of This Report Table 247. Secondary Sources Table 248. Primary Sources List of Figures Figure 1. Josamycin Image Figure 2. Global Josamycin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Josamycin Market Size Share 2021 VS 2025 VS 2032 Figure 4. 99% Purity Type Image Figure 5. 98% Purity Type Image Figure 6. 95% Purity Type Image Figure 7. Others Image Figure 8. Global Josamycin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Josamycin Market Size Share 2021 VS 2025 VS 2032 Figure 10. Josamycin Tablets Image Figure 11. Propidinium Propionate Granule Image Figure 12. Others Image Figure 13. Global Josamycin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Josamycin Revenue (2021-2032) & (US$ Million) Figure 15. Global Josamycin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Josamycin Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Josamycin Revenue Market Share by Region (2021-2032) Figure 18. Global Josamycin Sales (2021-2032) & (tons) Figure 19. Global Josamycin Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 20. Global Josamycin Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Josamycin Sales YoY (2021-2032) & (tons) Figure 22. Europe Josamycin Sales YoY (2021-2032) & (tons) Figure 23. China Josamycin Sales YoY (2021-2032) & (tons) Figure 24. Asia (Excluding China) Josamycin Sales YoY (2021-2032) & (tons) Figure 25. South America, Middle East and Africa Josamycin Sales YoY (2021-2032) & (tons) Figure 26. Global Josamycin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Josamycin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Josamycin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Josamycin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Josamycin Revenue Market Share by Type (2021-2032) Figure 32. Global Josamycin Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 33. Global Josamycin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Josamycin Sales Market Share by Type (2021-2032) Figure 35. Global Josamycin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Josamycin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Josamycin Revenue Market Share by Application (2021-2032) Figure 38. Global Josamycin Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 39. Global Josamycin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Josamycin Sales Market Share by Application (2021-2032) Figure 41. North America Josamycin Revenue Share by Type (2021-2032) Figure 42. North America Josamycin Sales Share by Type (2021-2032) Figure 43. North America Josamycin Revenue Share by Application (2021-2032) Figure 44. North America Josamycin Sales Share by Application (2021-2032) Figure 45. North America Josamycin Revenue Share by Country (2021-2032) Figure 46. North America Josamycin Sales Share by Country (2021-2032) Figure 47. Europe Josamycin Revenue Share by Type (2021-2032) Figure 48. Europe Josamycin Sales Share by Type (2021-2032) Figure 49. Europe Josamycin Revenue Share by Application (2021-2032) Figure 50. Europe Josamycin Sales Share by Application (2021-2032) Figure 51. Europe Josamycin Revenue Share by Country (2021-2032) Figure 52. Europe Josamycin Sales Share by Country (2021-2032) Figure 53. China Josamycin Revenue Share by Type (2021-2032) Figure 54. China Josamycin Sales Share by Type (2021-2032) Figure 55. China Josamycin Revenue Share by Application (2021-2032) Figure 56. China Josamycin Sales Share by Application (2021-2032) Figure 57. Asia Josamycin Revenue Share by Type (2021-2032) Figure 58. Asia Josamycin Sales Share by Type (2021-2032) Figure 59. Asia Josamycin Revenue Share by Application (2021-2032) Figure 60. Asia Josamycin Sales Share by Application (2021-2032) Figure 61. Asia Josamycin Revenue Share by Country (2021-2032) Figure 62. Asia Josamycin Sales Share by Country (2021-2032) Figure 63. SAMEA Josamycin Revenue Share by Type (2021-2032) Figure 64. SAMEA Josamycin Sales Share by Type (2021-2032) Figure 65. SAMEA Josamycin Revenue Share by Application (2021-2032) Figure 66. SAMEA Josamycin Sales Share by Application (2021-2032) Figure 67. SAMEA Josamycin Revenue Share by Country (2021-2032) Figure 68. SAMEA Josamycin Sales Share by Country (2021-2032) Figure 69. Josamycin Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Josamycin Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 99% Purity Type
  • 98% Purity Type
  • 95% Purity Type
  • Others
Applications
  • Josamycin Tablets
  • Propidinium Propionate Granule
  • Others
Companies covered
  • Tosun Pharm
  • CSPC
  • SINE
  • Minsheng Pharma
  • BioChemPartner
  • Guilin Pharma
  • Bayer
  • Guanghua Pharma
  • SAJA Pharma
  • Ferrer International
  • Dragon Pharm
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Josamycin Market by Type
  3. 1.2.1 Global Josamycin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 99% Purity Type
  5. 1.2.3 98% Purity Type
  6. 1.2.4 95% Purity Type
  7. 1.2.5 Others
  8. 1.3 Josamycin Market by Application
  9. 1.3.1 Global Josamycin Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Josamycin Tablets
  11. 1.3.3 Propidinium Propionate Granule
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Josamycin Market Dynamics
  1. 2.1 Josamycin Industry Trends
  2. 2.2 Josamycin Industry Drivers
  3. 2.3 Josamycin Industry Opportunities and Challenges
  4. 2.4 Josamycin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Josamycin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Josamycin Revenue by Region
  3. 3.2.1 Global Josamycin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Josamycin Revenue by Region (2021-2026)
  5. 3.2.3 Global Josamycin Revenue by Region (2027-2032)
  6. 3.2.4 Global Josamycin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Josamycin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Josamycin Sales by Region
  9. 3.4.1 Global Josamycin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Josamycin Sales by Region (2021-2026)
  11. 3.4.3 Global Josamycin Sales by Region (2027-2032)
  12. 3.4.4 Global Josamycin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Josamycin Revenue by Manufacturers
  2. 4.1.1 Global Josamycin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Josamycin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Josamycin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Josamycin Sales by Manufacturers
  6. 4.2.1 Global Josamycin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Josamycin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Josamycin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Josamycin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Josamycin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Josamycin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Josamycin Manufacturers, Product Type & Application
  13. 4.7 Global Josamycin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Josamycin Market CR5 and HHI
  16. 4.8.2 2025 Josamycin Tier 1, Tier 2, and Tier 3
5 Josamycin Market by Type
  1. 5.1 Global Josamycin Revenue by Type
  2. 5.1.1 Global Josamycin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Josamycin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Josamycin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Josamycin Sales by Type
  6. 5.2.1 Global Josamycin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Josamycin Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Josamycin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Josamycin Price by Type
6 Josamycin Market by Application
  1. 6.1 Global Josamycin Revenue by Application
  2. 6.1.1 Global Josamycin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Josamycin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Josamycin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Josamycin Sales by Application
  6. 6.2.1 Global Josamycin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Josamycin Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Josamycin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Josamycin Price by Application
7 Company Profiles
  1. 7.1 Tosun Pharm
  2. 7.1.1 Tosun Pharm Company Information
  3. 7.1.2 Tosun Pharm Business Overview
  4. 7.1.3 Tosun Pharm Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Tosun Pharm Josamycin Product Portfolio
  6. 7.1.5 Tosun Pharm Recent Developments
  7. 7.2 CSPC
  8. 7.2.1 CSPC Company Information
  9. 7.2.2 CSPC Business Overview
  10. 7.2.3 CSPC Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSPC Josamycin Product Portfolio
  12. 7.2.5 CSPC Recent Developments
  13. 7.3 SINE
  14. 7.3.1 SINE Company Information
  15. 7.3.2 SINE Business Overview
  16. 7.3.3 SINE Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 SINE Josamycin Product Portfolio
  18. 7.3.5 SINE Recent Developments
  19. 7.4 Minsheng Pharma
  20. 7.4.1 Minsheng Pharma Company Information
  21. 7.4.2 Minsheng Pharma Business Overview
  22. 7.4.3 Minsheng Pharma Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Minsheng Pharma Josamycin Product Portfolio
  24. 7.4.5 Minsheng Pharma Recent Developments
  25. 7.5 BioChemPartner
  26. 7.5.1 BioChemPartner Company Information
  27. 7.5.2 BioChemPartner Business Overview
  28. 7.5.3 BioChemPartner Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 BioChemPartner Josamycin Product Portfolio
  30. 7.5.5 BioChemPartner Recent Developments
  31. 7.6 Guilin Pharma
  32. 7.6.1 Guilin Pharma Company Information
  33. 7.6.2 Guilin Pharma Business Overview
  34. 7.6.3 Guilin Pharma Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Guilin Pharma Josamycin Product Portfolio
  36. 7.6.5 Guilin Pharma Recent Developments
  37. 7.7 Bayer
  38. 7.7.1 Bayer Company Information
  39. 7.7.2 Bayer Business Overview
  40. 7.7.3 Bayer Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bayer Josamycin Product Portfolio
  42. 7.7.5 Bayer Recent Developments
  43. 7.8 Guanghua Pharma
  44. 7.8.1 Guanghua Pharma Company Information
  45. 7.8.2 Guanghua Pharma Business Overview
  46. 7.8.3 Guanghua Pharma Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Guanghua Pharma Josamycin Product Portfolio
  48. 7.8.5 Guanghua Pharma Recent Developments
  49. 7.9 SAJA Pharma
  50. 7.9.1 SAJA Pharma Company Information
  51. 7.9.2 SAJA Pharma Business Overview
  52. 7.9.3 SAJA Pharma Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 SAJA Pharma Josamycin Product Portfolio
  54. 7.9.5 SAJA Pharma Recent Developments
  55. 7.10 Ferrer International
  56. 7.10.1 Ferrer International Company Information
  57. 7.10.2 Ferrer International Business Overview
  58. 7.10.3 Ferrer International Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ferrer International Josamycin Product Portfolio
  60. 7.10.5 Ferrer International Recent Developments
  61. 7.11 Dragon Pharm
  62. 7.11.1 Dragon Pharm Company Information
  63. 7.11.2 Dragon Pharm Business Overview
  64. 7.11.3 Dragon Pharm Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Dragon Pharm Josamycin Product Portfolio
  66. 7.11.5 Dragon Pharm Recent Developments
  67. 7.12 Astellas
  68. 7.12.1 Astellas Company Information
  69. 7.12.2 Astellas Business Overview
  70. 7.12.3 Astellas Josamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Astellas Josamycin Product Portfolio
  72. 7.12.5 Astellas Recent Developments
8 North America
  1. 8.1 North America Josamycin Market Size by Type
  2. 8.1.1 North America Josamycin Revenue by Type (2021-2032)
  3. 8.1.2 North America Josamycin Sales by Type (2021-2032)
  4. 8.1.3 North America Josamycin Price by Type (2021-2032)
  5. 8.2 North America Josamycin Market Size by Application
  6. 8.2.1 North America Josamycin Revenue by Application (2021-2032)
  7. 8.2.2 North America Josamycin Sales by Application (2021-2032)
  8. 8.2.3 North America Josamycin Price by Application (2021-2032)
  9. 8.3 North America Josamycin Market Size by Country
  10. 8.3.1 North America Josamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Josamycin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Josamycin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Josamycin Market Size by Type
  2. 9.1.1 Europe Josamycin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Josamycin Sales by Type (2021-2032)
  4. 9.1.3 Europe Josamycin Price by Type (2021-2032)
  5. 9.2 Europe Josamycin Market Size by Application
  6. 9.2.1 Europe Josamycin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Josamycin Sales by Application (2021-2032)
  8. 9.2.3 Europe Josamycin Price by Application (2021-2032)
  9. 9.3 Europe Josamycin Market Size by Country
  10. 9.3.1 Europe Josamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Josamycin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Josamycin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Josamycin Market Size by Type
  2. 10.1.1 China Josamycin Revenue by Type (2021-2032)
  3. 10.1.2 China Josamycin Sales by Type (2021-2032)
  4. 10.1.3 China Josamycin Price by Type (2021-2032)
  5. 10.2 China Josamycin Market Size by Application
  6. 10.2.1 China Josamycin Revenue by Application (2021-2032)
  7. 10.2.2 China Josamycin Sales by Application (2021-2032)
  8. 10.2.3 China Josamycin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Josamycin Market Size by Type
  2. 11.1.1 Asia Josamycin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Josamycin Sales by Type (2021-2032)
  4. 11.1.3 Asia Josamycin Price by Type (2021-2032)
  5. 11.2 Asia Josamycin Market Size by Application
  6. 11.2.1 Asia Josamycin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Josamycin Sales by Application (2021-2032)
  8. 11.2.3 Asia Josamycin Price by Application (2021-2032)
  9. 11.3 Asia Josamycin Market Size by Country
  10. 11.3.1 Asia Josamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Josamycin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Josamycin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Josamycin Market Size by Type
  2. 12.1.1 SAMEA Josamycin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Josamycin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Josamycin Price by Type (2021-2032)
  5. 12.2 SAMEA Josamycin Market Size by Application
  6. 12.2.1 SAMEA Josamycin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Josamycin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Josamycin Price by Application (2021-2032)
  9. 12.3 SAMEA Josamycin Market Size by Country
  10. 12.3.1 SAMEA Josamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Josamycin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Josamycin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Josamycin Value Chain Analysis
  2. 13.1.1 Josamycin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Josamycin Production Mode & Process
  6. 13.2 Josamycin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Josamycin Distributors
  9. 13.2.3 Josamycin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst